Login
← Go Back
Novartis India
NOVARTIND · Retail > Trading · Chairman: C Snook · MD: Sanjay Murdeshwar · Listing date: Nov. 9, 2000 · Employees: 539 · Mumbai · http://www.novartis.in
Stock Price vs Company Growth
1d
3.1%
1w
7.1%
1m
9.8%
3m
52.7%
6m
97.2%
1y
58.9%
5y
13.7%
all
18.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,579 3.1%
1,011
1,778
Company Overview
Sales
371 Cr
Growth: 0.6%
Profit after Tax
97.8 Cr
Growth: 4.9%
Small Cap
3,898 Cr
P/E: 39.9x
Industry P/E: 27.3x
Fundamentals
Sales (Cr) ₹ 371
Growth 0.6%
EBITDA 27.5%
P/S 10.5x
Dividend 2.4%
P/E 39.9x
Book Value ₹ 344
PEG Ratio 71.3x
ROE 11.6%
P/B 4.6x
Shareholding Pattern
Institutions
Promoters
Novartis Ag
70.68 %
Others
Atul Limited
1.52 %
Iepf
0.47 %
Llp, Partnership Firm, Directors' Relative
0.14 %
Increase    Decrease    No change
Company Profile Detailed
As a science-based and patient-oriented healthcare company, it strives to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Belongs to (9 Indices) view more
Investors (7)
abdul.ha...
iepf
total
Followers (1)
varsha96